Novacyt Sa operates in the Electromedical equipment sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Novacyt Sa with three other
companies in this sector in FRANCE :
sales of 4.52 million Euro [US$5.41 million]
of which 100%
Mauna Kea Technologies SAS
(7.43 million Euro [US$8.89 million]
of which 55%
was Miniprobe), and
(9.64 million Euro [US$11.53 million]
Novacyt Sa reported sales of 13.08 million Euro (US$15.65 million)
December of 2019.
decrease of 4.7%
versus 2018, when the company's sales were 13.72 million Euro.
Contributing to the drop in overall sales was the 9.7% decline
in Diagnostic, from 7.50 million Euro to 6.77 million Euro.
However, these declines were partially offset by the increase in sales of
Molecular Screening (up 1.4% to 6.31 million Euro)